Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects

SM Evans, EJ Cone and JE Henningfield

Addiction Research Center, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA.

Arterial plasma drug concentrations should be a strong predictor of resultant physiological and behavioral effects of smoked drugs. Nine healthy male volunteers, who were current users of smoked and i.v. cocaine, participated in a study directly comparing arterial and venous cocaine plasma concentrations after smoked and i.v. cocaine. Each volunteer was first tested under all dosing conditions without an arterial catheter (phase I), to determine whether subjects could tolerate each cocaine dose, before testing with an arterial catheter (phase II). Phase II consisted of two test days, each consisting of either four smoked-cocaine sessions (sham, 12.5, 25 and 50 mg) or four i.v. cocaine sessions (0, 8, 16 and 32 mg) in ascending order, spaced 90 min apart. For the two highest doses for each route, arterial and venous blood samples were taken simultaneously before drug administration, during drug administration and frequently after drug administration. At the same time, cardiovascular effects and subjective effects were measured. Arterial cocaine concentrations were substantially higher than venous cocaine concentrations after both routes of cocaine administration. After either smoked or i.v. cocaine, maximal arterial cocaine concentrations occurred within 15 sec, whereas maximal venous cocaine concentrations occurred within 4 min. The onset of cardiovascular and subjective effects was also rapid, and arterial cocaine concentrations tended to account for these effects to a greater extent than did venous cocaine concentrations. Even though arterial and venous cocaine concentrations were lower after smoked cocaine, compared with i.v. cocaine, the magnitudes of cardiovascular and subjective effects were similar, suggesting that smoked cocaine may produce a greater effect at similar concentrations. These findings do not support the hypothesis that the greater effects observed after smoking are a result of smoked cocaine reaching the brain faster than i.v. cocaine as measured by peripheral arterial plasma concentrations.

Volume 279, Issue 3, pp. 1345-1356, 12/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. S. Fowler, J. Logan, G.-J. Wang, N. D. Volkow, F. Telang, W. Zhu, D. Franceschi, C. Shea, V. Garza, Y. Xu, et al. Comparison of Monoamine Oxidase A in Peripheral Organs in Nonsmokers and Smokers J. Nucl. Med., September 1, 2005; 46(9): 1414 - 1420. [Abstract] [Full Text] [PDF]

				J. H. Mendelson, M. B. Sholar, N. H. Mutschler, M. Jaszyna-Gasior, N. V. Goletiani, A. J. Siegel, and N. K. Mello Effects of Intravenous Cocaine and Cigarette Smoking on Luteinizing Hormone, Testosterone, and Prolactin in Men J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 339 - 348. [Abstract] [Full Text] [PDF]

				J. H. Mendelson, M. B. Sholar, A. J. Siegel, and N. K. Mello Effects of Cocaine on Luteinizing Hormone in Women during the Follicular and Luteal Phases of the Menstrual Cycle and in Men J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 972 - 979. [Abstract] [Full Text]

				T. J. Baird, S.-X. Deng, D. W. Landry, G. Winger, and J. H. Woods Natural and Artificial Enzymes Against Cocaine. I. Monoclonal Antibody 15A10 and the Reinforcing Effects of Cocaine in Rats J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1127 - 1134. [Abstract] [Full Text]

				L. E. Bayer, A. Brown, C. F. Mactutus, R. M. Booze, and B. J. Strupp Prenatal Cocaine Exposure Increases Sensitivity to the Attentional Effects of the Dopamine D1 Agonist SKF81297 J. Neurosci., December 1, 2000; 20(23): 8902 - 8908. [Abstract] [Full Text] [PDF]

				J. H. Mendelson, N. K. Mello, and S. S. Negus Effects of Luteinizing Hormone-Releasing Hormone on Plasma Cocaine Levels in Rhesus Monkeys J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 791 - 799. [Abstract] [Full Text]

				C. E. Lau, F. Ma, D. M. Foster, and J. L. Falk Pharmacokinetic-Pharmacodynamic Modeling of the Psychomotor Stimulant Effect of Cocaine after Intravenous Administration: Timing Performance Deficits J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 535 - 543. [Abstract] [Full Text]

				M. J. Kaufman, J. M. Levin, M. H. Ross, N. Lange, S. L. Rose, T. J. Kukes, J. H. Mendelson, S. E. Lukas, B. M. Cohen, and P. F. Renshaw Cocaine-Induced Cerebral Vasoconstriction Detected in Humans With Magnetic Resonance Angiography JAMA, February 4, 1998; 279(5): 376 - 380. [Abstract] [Full Text] [PDF]

				J.E. Henningfield, R.V. Fant, and S.L. Tomar Smokeless Tobacco: an Addicting Drug Advances in Dental Research, September 1, 1997; 11(3): 330 - 335. [Abstract] [PDF]